Мometasone furoate/formoterol: new fixed-dose combination in the treatment of bronchial asthma
The medical and social significance of bronchial asthma (BA) is explained by its high incidence (5-10%), dramatic decline in the quality of life of patients and high cost of treatment. Severe exacerbations of asthma may cause death at any age. Studies carried out in different countries of the world...
Main Author: | A. V. Еmelyanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2013-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1141 |
Similar Items
-
Efficacy and safety of mometasone furoate/formoterol combination in patients with bronchial asthma
by: A. V. Emelyanov
Published: (2015-12-01) -
Drug therapy of allergic rhinitis in children
by: E. P. Karpova, et al.
Published: (2013-12-01) -
Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01) -
Managing pollen asthma with a single inhaler: a case study
by: N. M. Nenasheva
Published: (2015-12-01) -
Rational therapy of asthma in children with inhaled corticosteroids
by: N. A. Geppe, et al.
Published: (2016-12-01)